Application is a critical axis of Peritoneoscopes segmentation, with two primary categories: Diagnostic and Therapeutic. The Diagnostic segment dominates the market, driven by the increasing prevalence of abdominal pathologies and the demand for minimally invasive diagnostic procedures. This segment accounts for approximately 60% of the market, fueled by the adoption of peritoneoscopes for imaging, tissue biopsy, and intraoperative assessment. Conversely, the Therapeutic segment, representing 40% of the market, is propelled by advancements in robotic-assisted surgeries and the rising incidence of conditions like endometriosis and appendicitis. Therapeutic applications include surgical excision, adhesion lysis, and drainage, where real-time visualization improves procedural accuracy. The diagnostic segmentโs growth is further supported by hospital and ambulatory surgical center investments in cost-efficient diagnostic tools, while the therapeutic segment benefits from technological innovations in multifunctional devices. These subcategories collectively define the peritoneoscopes market size, reflecting a balance between diagnostic precision and therapeutic intervention demands.